Eric Mosbrooker has over 20 years of experience in global commercial operations, with demonstrated leadership and experience in global pricing, marketing, distribution, product launches, and compliance. In addition to his commercial experience, Mr. Mosbrooker has expertise in gene therapy, rare metabolic diseases, additional orphan conditions and oncology. Most recently, Mr. Mosbrooker served as the Chief Operations Officer for Cognoa, leading the commercial, program management, product, and business operations functions. Before Cognoa, he was the Chief Commercial Officer at Audentes Therapeutics overseeing the gene therapy business unit and the Senior Vice President of the Global Orphan Business Unit at Horizon Pharmaceuticals. He holds a B.S. in Industrial Engineering from the University of Wisconsin – Madison.